Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +0.75% | -13.18% | -40.00% |
Business Summary
Number of employees: 168
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 20-04-30 |
Chief Tech/Sci/R&D Officer | 51 | 20-10-31 | |
Eyal Attar
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-10-11 |
Sarah Spencer
IRC | Investor Relations Contact | - | - |
Tania Philipp
HRO | Human Resources Officer | 52 | 19-11-30 |
John C. King
PRN | Corporate Officer/Principal | 49 | 20-07-31 |
General Counsel | 76 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 20-07-29 |
Matt Patterson
CHM | Chairman | 52 | 20-10-19 |
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Bill Lundberg
BRD | Director/Board Member | 60 | 19-02-28 |
Daniella Beckman
BRD | Director/Board Member | 45 | 20-07-15 |
Joshua Resnick
BRD | Director/Board Member | 49 | 19-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,269,901 | 67,481,107 ( 98.84 %) | 0 | 98.84 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.00% | 92.15M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- VOR Stock
- Company Vor Biopharma Inc.